Information was received from a patient via a manufacturer's representative (rep) regarding a patient who was receiving 2200mcg/ml b aclofen at 695.1mcg/day and 12.5mg/ml morphine at 3.950mg/day via an implantable infusion pump for multiple sclerosis.It was reported that the patient experienced increased spasticity, periods of increased sedation, and increased pain.It was reported that a low reservoir alarm occurred on (b)(6) 2017 at 01:02.An empty reservoir alarm occurred on (b)(6) 2017 at 08:24.The patient was admitted to the hospital for the increased spasticity and pain.The patient had spasms of the upper extremities every 3-5 minutes.The patient reported their old doctor stopped managing their pump because they had "missed too many appointments." the patient's primary care physician signed off for them to get their pump filled last june, but they did not currently have a managing physician.The rep spoke with one of the attending physicians and relayed information about the alarm dates, previously infusing drugs and rates, and concern of potential damage to the internal tubing if pump continued to run without medication.No interventions had been taken at the time of the report.The patient was under inpatient medical treatment at the time of the report.The issue was not resolved at the time of the report.The patient status at the time of the report was noted as "alive-no injury." it was reported in the pump logs that a motor stall occurred on (b)(6) 2017 at 15:16 and a motor stall recovery occurred on (b)(6) 2017 at 15:34.No further complications were anticipated/reported.
|